Liver biopsy

These recommendations provide a data-supported approach. They are based on the following: (1) formal review and analysis of the recently published world literature on the topic; (2) American College of Physicians Manual for Assessing Health Practices and Designing Practice Guidelines1; (3) guideline policies, including the AASLD Policy on the Development and Use of Practice Guidelines and the American Gastroenterological Association Policy Statement on Guidelines2; and (4) the experience of the authors in the specified topic. Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. They are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case. Specific recommendations are based on relevant published information. To more fully characterize the quality of evidence supporting recommendations, the Practice Guidelines Committee of the AASLD requires a Class (reflecting benefit versus risk) and Level (assessing strength or certainty) of Evidence to be assigned and reported with each recommendation (Table 1, adapted from the American College of Cardiology and the American Heart Association Practice Guidelines3).4

[1]  N. Mcintyre,et al.  A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. , 1993, Journal of hepatology.

[2]  L. Castéra,et al.  Patient-administered nitrous oxide/oxygen inhalation provides safe and effective analgesia for percutaneous liver biopsy: A randomized placebo-controlled trial , 2001, American Journal of Gastroenterology.

[3]  B. Bacon,et al.  Histological evaluation of iron in liver biopsies: relationship to HFE mutations , 2000, American Journal of Gastroenterology.

[4]  S. Caldwell,et al.  Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.

[5]  A. Reuben Just a second , 2003, Hepatology.

[6]  Y. Baruch,et al.  Prevalence and Characteristics of Pain Induced by Percutaneous Liver Biopsy , 2003, Anesthesia and analgesia.

[7]  T. Therneau,et al.  An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities , 2000, American Journal of Gastroenterology.

[8]  J H Lewis,et al.  Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey. , 2001, Digestive diseases and sciences.

[9]  M. Fried,et al.  Practice and complications of liver biopsy , 1993, Digestive Diseases and Sciences.

[10]  Michael A. Choti,et al.  Preoperative Assessment of Hepatocellular Carcinoma Tumor Grade Using Needle Biopsy: Implications for Transplant Eligibility , 2007, Annals of surgery.

[11]  American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers. , 1995, Gastroenterology.

[12]  M. Schilsky,et al.  Diagnosis and treatment of Wilson disease: An update , 2008, Hepatology.

[13]  E. Cholongitas,et al.  Ultrasound‐guided liver biopsy in real life: Comparison of same‐day prebiopsy versus real‐time ultrasound approach , 2007, Journal of gastroenterology and hepatology.

[14]  J. Crawford Evidence-based interpretation of liver biopsies , 2006, Laboratory Investigation.

[15]  S. Jasko,et al.  Therapy , 1881, The American journal of dental science.

[16]  I. Dvorchik,et al.  Should we biopsy each liver mass suspicious for hepatocellular carcinoma before liver transplantation?--yes. , 2005, Journal of hepatology.

[17]  F. Lirussi,et al.  Laparoscopy and Liver Biopsy: Further Evidence that the Two Procedures Improve the Diagnosis of Liver Cirrhosis A Retrospective Study of 1,003 Consecutive Examinations R. Orlando, M.D , 1990, Journal of clinical gastroenterology.

[18]  K. Lindor,et al.  Outcome of Patients Hospitalized for Complications after Outpatient Liver Biopsy , 1993, Annals of Internal Medicine.

[19]  D. Rockey,et al.  Pyogenic liver abscess. Changes in etiology, management, and outcome. , 1996, Medicine.

[20]  K. Niezen-Koning,et al.  Type IIIb glycogen storage disease associated with end‐stage cirrhosis and hepatocellular carcinoma , 1997, Hepatology.

[21]  P. Mannucci,et al.  Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. , 2007, Journal of hepatology.

[22]  Aniruddha M. Deshpande,et al.  Standardized Reporting of Clinical Practice Guidelines: A Proposal from the Conference on Guideline Standardization , 2003, Annals of Internal Medicine.

[23]  H. Karakayalı,et al.  Value of an individual liver biopsy in the preoperative evaluation of apparently healthy potential liver donors , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[24]  D. Kane,et al.  Survey of arthroscopy performed by rheumatologists. , 2002, Rheumatology.

[25]  R. Heyn,et al.  Pretreatment liver biopsy in 20 children with histiocytosis X: a clinicopathologic correlation. , 1990, Medical and Pediatric Oncology.

[26]  A. Burroughs,et al.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. , 1995, Gut.

[27]  J Rakela,et al.  The role of ultrasonography and automatic‐needle biopsy in outpatient percutaneous liver biopsy , 1996, Hepatology.

[28]  A. Czaja,et al.  Optimizing diagnosis from the medical liver biopsy. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  E. Schiff,et al.  The role of laparoscopy in the diagnosis of cirrhosis. , 1996, Gastrointestinal endoscopy.

[30]  D. Jain,et al.  Liver disease in patients with hereditary hemorrhagic telangiectasia. , 2000, The New England journal of medicine.

[31]  S. Brunskill,et al.  Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials , 2004, British journal of haematology.

[32]  A. fong,et al.  Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[33]  J. Segal,et al.  Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence‐based review , 2005, Transfusion.

[34]  H. Fukui,et al.  Cryptogenic cirrhosis in the region where obesity is not prevalent. , 2006, World journal of gastroenterology.

[35]  W. Hathaway,et al.  Use of DDAVP in inherited and acquired platelet dysfunction , 1990, American journal of hematology.

[36]  Samuel Chang,et al.  Needle tract implantation after sonographically guided percutaneous biopsy of hepatocellular carcinoma: evaluation of doubling time, frequency, and features on CT. , 2005, AJR. American journal of roentgenology.

[37]  G. Minuk,et al.  Clinical hepatology: Profile of an urban, hospital‐based practic , 1996, Hepatology.

[38]  T. Ganiats,et al.  Ultrasound-Guided Liver Biopsy for Parenchymal Liver Disease (An Economic Analysis) , 2004, Digestive Diseases and Sciences.

[39]  P. Toy,et al.  Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. , 1990, American journal of clinical pathology.

[40]  C. Jacquelinet,et al.  Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. , 1992, Gastroenterology.

[41]  C. González Hernández,et al.  [Cryptogenic cirrhosis?]. , 1999, Anales de medicina interna.

[42]  G. Brancatelli Science to practice: Should biopsy be performed in potential liver donors when unenhanced CT shows an unacceptable degree of steatosis for transplantation? , 2006, Radiology.

[43]  Christos Christidis,et al.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C , 2005, Hepatology.

[44]  V. Beutel,et al.  Prospective Randomized Trial of Post-liver Biopsy Recovery Positions: Does Positioning Really Matter? , 2005, Journal of clinical gastroenterology.

[45]  R. McCallum,et al.  Variation between centers in technique and guidelines for liver biopsy. , 2008, Liver.

[46]  D. Triulzi The art of plasma transfusion therapy , 2006, Transfusion.

[47]  P. Thampanitchawong,et al.  Liver biopsy:complications and risk factors. , 1999, World journal of gastroenterology.

[48]  S. Klauck,et al.  Large-needle biopsy versus thin-needle biopsy in diagnostic pathology of liver diseases. , 2001, Liver.

[49]  G. Alexander,et al.  The role for liver biopsy in haemophiliacs infected with the hepatitis C virus , 1997, British journal of haematology.

[50]  Xi-Zhang Lin,et al.  The normal adult human liver biopsy: A quantitative reference standard , 1998, Hepatology.

[51]  P. Schlichting,et al.  Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. , 1980, Scandinavian journal of gastroenterology.

[52]  J. McHutchison,et al.  American Gastroenterological Association technical review on the management of hepatitis C. , 2006, Gastroenterology.

[53]  G. Dodd,et al.  Image-guided percutaneous hepatic biopsy: effect of ascites on the complication rate. , 1996, Radiology.

[54]  D. Purdie,et al.  Steatosis is a cofactor in liver injury in hemochromatosis. , 2005, Gastroenterology.

[55]  L. Seeff,et al.  Aasld Practice Guideline Diagnosis, Management, and Treatment of Hepatitis C , 2003 .

[56]  M. Taniai,et al.  Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH , 2004, Journal of Gastroenterology.

[57]  L. Weisenthal,et al.  Delayed hemorrhage after percutaneous liver biopsy. , 1983, Journal of clinical gastroenterology.

[58]  D. Rajan,et al.  Pain after percutaneous liver biopsy for diffuse hepatic disease: a randomized trial comparing subcostal and intercostal approaches. , 2005, Journal of vascular and interventional radiology : JVIR.

[59]  J. Ludwig,et al.  Two cases from the spectrum of nonalcoholic steatohepatitis. , 1995, Journal of clinical gastroenterology.

[60]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[61]  R. Bruno,et al.  Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. , 2004, Journal of hepatology.

[62]  M. Colombo,et al.  Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. , 1988, Gastroenterology.

[63]  X. Forns,et al.  Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation , 2006, Hepatology.

[64]  Dermot Kelleher,et al.  Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. , 1999, Journal of hepatology.

[65]  J. Devière,et al.  Management of anticoagulants before and after endoscopy. , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[66]  M. Haberal,et al.  Liver biopsy is mandatory to choose suitable liver grafts. , 2003, Transplantation proceedings.

[67]  F. Carrat,et al.  The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. , 2005, Gastroenterology.

[68]  J. Glaser,et al.  [The risk of liver biopsy]. , 1995, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.

[69]  G. Gerken,et al.  Preoperative donor liver biopsy for adult living donor liver transplantation: Risks and benefits , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[70]  M. Schilsky,et al.  A practice guideline on Wilson disease , 2003, Hepatology.

[71]  E. Mezey,et al.  Sampling variability on percutaneous liver biopsy. , 1979, Archives of internal medicine.

[72]  R. P. Thompson,et al.  Experience with transjugular liver biopsy. , 1983, Gut.

[73]  S. Cotler,et al.  Liver Transplantation for Hepatocellular Carcinoma: A Survey of Practices , 2006, Journal of clinical gastroenterology.

[74]  William M. Lee,et al.  AASLD Position Paper: The Management of Acute Liver Failure: Update 2011 , 2011 .

[75]  K. Lindor,et al.  Utility of liver biopsy in bone marrow transplant patients , 2008, Journal of gastroenterology and hepatology.

[76]  H. Kumada,et al.  [Chronic hepatitis B]. , 2001, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[77]  O. Chazouilleres,et al.  A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology , 2007, Hepatology.

[78]  P. Hall,et al.  Small gauge gelfoam plug liver biopsy in high risk patients: safety and diagnostic value. , 1996, Australasian radiology.

[79]  E. Heathcote Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. , 2000, Hepatology.

[80]  P. Beddy,et al.  Outpatient liver biopsy: a prospective evaluation of 500 cases , 2006, Gut.

[81]  D. Rockey,et al.  Noninvasive measures of liver fibrosis , 2006, Hepatology.

[82]  L. Ferrell,et al.  Cirrhosis of undefined pathogenesis: Absence of evidence for unknown viruses or autoimmune processes , 1993, Hepatology.

[83]  S. Sherlock ASPIRATION LIVER BIOPSY: TECHNIQUE AND DIAGNOSTIC APPLICATION , 1945 .

[84]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[85]  C. Clerici,et al.  Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis , 2003, Hepatology.

[86]  Chao-Long Chen,et al.  Needle Tract Implantation of Hepatocellular Carcinoma After Fine Needle Biopsy , 2006, Digestive Diseases and Sciences.

[87]  A. Dube,et al.  Spectrum of Liver Histology in Presumed Decompensated Alcoholic Liver Disease , 2007, The American Journal of Gastroenterology.

[88]  M. Stone,et al.  An audit of ultrasound guided liver biopsies: a need for evidence-based practice. , 1996, Hepato-gastroenterology.

[89]  T. Berg,et al.  DISTINCT ENZYME PROFILES IN PATIENTS WITH CRYPTOGENIC CIRRHOSIS REFLECT HETEROGENEOUS CAUSES WITH DIFFERENT OUTCOMES AFTER LIVER TRANSPLANTATION (OLT): A LONG-TERM DOCUMENTATION BEFORE AND AFTER OLT , 2002, Transplantation.

[90]  T. Riley Predictors of Pain Medication Use After Percutaneous Liver Biopsy , 2002, Digestive Diseases and Sciences.

[91]  E. Arbustini,et al.  Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families. , 2004, Gastroenterology.

[92]  D. Faigel,et al.  Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. , 2002, Gastrointestinal endoscopy.

[93]  B. Gridelli,et al.  Contribution of Transjugular Liver Biopsy in Patients with the Clinical Presentation of Acute Liver Failure , 2006, CardioVascular and Interventional Radiology.

[94]  S. Sherlock,et al.  Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. , 1993, The Journal of pediatrics.

[95]  R. Superina,et al.  Liver cell dysplasia and early liver transplantation in hereditary tyrosinemia. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[96]  M. Colombo,et al.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. , 1986, Journal of hepatology.

[97]  M. Banaji,et al.  The risk of bleeding after percutaneous liver biopsy: relation to platelet count. , 1982, Journal of clinical gastroenterology.

[98]  D. Thorburn,et al.  The Importance of Liver Biopsy in the Investigation of Possible Mitochondrial Respiratory Chain Disease , 2005, Neuropediatrics.

[99]  P. Hayes,et al.  Liver biopsy bleeding time: An unpredictable event , 1994, Journal of gastroenterology and hepatology.

[100]  B. Konkle,et al.  Defining effective therapies in transfusion medicine and hemostasis: new opportunities with the TMH Network , 2005, Transfusion.

[101]  R C Nelson,et al.  Percutaneous liver biopsy: a cost-benefit analysis comparing sonographic and CT guidance. , 1999, AJR. American journal of roentgenology.

[102]  K. Badizadegan,et al.  Focal glycogenosis of the liver in disorders of ureagenesis: Its occurrence and diagnostic significance , 1997, Hepatology.

[103]  A. Tavill Diagnosis and management of hemochromatosis , 2001, Hepatology.

[104]  V. Nobili,et al.  Blind and ultrasound-guided percutaneous liver biopsy in children , 2003, Pediatric Radiology.

[105]  P. Giral,et al.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.

[106]  G. Remuzzi,et al.  Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. , 1983, The New England journal of medicine.

[107]  C. M. Jones,et al.  The diagnostic and therapeutic value of liver biopsies with particular reference to trocar biopsy. , 1947, The New England journal of medicine.

[108]  C. Bodian,et al.  Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[109]  Z. Younossi,et al.  Obesity and Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis C , 2004, Journal of clinical gastroenterology.

[110]  R. Hanson,et al.  The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.

[111]  J. Mayberry,et al.  A nationwide survey of liver biopsy--is there a need to increase resources, manpower and training? , 1994, Hepato-gastroenterology.

[112]  Sergey V Kantsevoy,et al.  Flexible transgastric peritoneoscopy and liver biopsy: a feasibility study in human beings (with videos). , 2008, Gastrointestinal endoscopy.

[113]  C. Avellini,et al.  The role of hepatic biopsy to detect macrovacuolar steatosis during liver procurement. , 2006, Transplantation proceedings.

[114]  R. Pilkington,et al.  Liver biopsy in Irish hepatitis C‐infected patients with inherited bleeding disorders , 2000, British journal of haematology.

[115]  W. Frankel,et al.  The value of second opinion in gastrointestinal and liver pathology. , 2001, Archives of pathology & laboratory medicine.

[116]  G. Leandro,et al.  Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. , 2003, Journal of hepatology.

[117]  J. Trotter,et al.  Changes in International Normalized Ratio (INR) and Model for Endstage Liver Disease (MELD) Based on Selection of Clinical Laboratory , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[118]  E. Cholongitas,et al.  Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review. , 2007, Journal of hepatology.

[119]  A. Grant,et al.  Guidelines on the use of liver biopsy in clinical practice , 1999, Gut.

[120]  J. Dimmick,et al.  Histopathologic Approach to Metabolic Liver Disease: Part 1 , 1998, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[121]  R. Dick,et al.  Liver biopsy today. The Royal Free Hospital experience. , 1985, Journal of hepatology.

[122]  J. Cosín,et al.  Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[123]  P. Thuluvath,et al.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study , 2000, Hepatology.

[124]  J. Janisse,et al.  Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[125]  J. Barbare,et al.  Is bleeding time measurement useful for choosing the liver biopsy route? The results of a pragmatic, prospective multicentric study in 219 patients. , 1999, Journal of clinical gastroenterology.

[126]  L. Sutherland,et al.  Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bed rest after percutaneous liver biopsy. , 1987, Gastroenterology.

[127]  M. Campbell,et al.  Noninvasive Assessment of Liver Fibrosis by Measurement of Stiffness in Patients With Chronic Hepatitis C , 2006 .

[128]  J. Pomposelli,et al.  Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. , 2002, Human pathology.

[129]  I. Gilmore,et al.  Plugged liver biopsy in patients with impaired coagulation , 1989, Digestive diseases and sciences.

[130]  R. Wiesner,et al.  Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy , 1991, Hepatology.

[131]  A. Tripodi,et al.  Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests , 2005, Hepatology.

[132]  A. Tripodi,et al.  The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end‐stage liver disease calculation , 2007, Hepatology.

[133]  E. Brunt,et al.  Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[134]  T. Reynolds,et al.  Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit , 2000, American Journal of Gastroenterology.

[135]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[136]  A. Burroughs,et al.  Should we biopsy each liver mass suspicious for HCC before liver transplantation?--no, please don't. , 2005, Journal of hepatology.

[137]  Z. Goodman,et al.  Liver Biopsy in Cirrhotic Patients , 2007, The American Journal of Gastroenterology.

[138]  D. Häussinger,et al.  Long-term survival in patients with hereditary hemochromatosis. , 1996, Gastroenterology.

[139]  N. Chalasani,et al.  Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. , 2002, Gastroenterology.

[140]  G. Norkrans,et al.  Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. , 2002, Journal of hepatology.

[141]  H. Hussain,et al.  Lack of tumor seeding of hepatocellular carcinoma after percutaneous needle biopsy using coaxial cutting needle technique. , 2006, AJR. American journal of roentgenology.

[142]  S. Caldwell Controlling pain in liver biopsy, or “we will probably need to repeat the biopsy in a year or two to assess the response” , 2001, American Journal of Gastroenterology.

[143]  T. Riley How often does ultrasound marking change the liver biopsy site? , 1999, American Journal of Gastroenterology.

[144]  J. Bruzzi,et al.  Liver biopsy. , 2001, The New England journal of medicine.

[145]  J. Ludwig,et al.  The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients , 1989, Hepatology.

[146]  B. Portmann,et al.  Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. , 2003, Blood.

[147]  P. Clavien,et al.  Medical Care of the Liver Transplant Patient , 2001 .

[148]  Fen-Yu Ren,et al.  Delayed hemorrhage from hepatic artery after ultrasound-guided percutaneous liver biopsy: a case report. , 2006, World journal of gastroenterology.

[149]  K. Lindor,et al.  When is liver biopsy needed in the diagnosis of primary biliary cirrhosis? , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[150]  Xiong Ma [The diagnosis and treatment of autoimmune hepatitis]. , 2010, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[151]  V. Vilgrain,et al.  Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. , 2001, Journal of hepatology.

[152]  Sheng-Nan Lu,et al.  Incidence of needle tract seeding and responses of soft tissue metastasis by hepatocellular carcinoma postradiotherapy , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[153]  S. Verma,et al.  Factors Predicting Relapse and Poor Outcome in Type I Autoimmune Hepatitis: Role of Cirrhosis Development, Patterns of Transaminases During Remission and Plasma Cell Activity in the Liver Biopsy , 2004, American Journal of Gastroenterology.

[154]  J. Hoofnagle,et al.  Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.

[155]  P. D. James,et al.  Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. , 2001, Journal of hepatology.

[156]  E. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[157]  K. Boberg,et al.  Is a Prolonged Bleeding Time Associated with an Increased Risk of Hemorrhage after Liver Biopsy? , 1999, Thrombosis and Haemostasis.

[158]  R. Fisher,et al.  Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[159]  A. Elola-Olaso,et al.  Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma? , 2005, Transplantation proceedings.

[160]  D. Dahlin,et al.  Laboratory and biopsy diagnosis of amyloidosis. , 1950, The Medical clinics of North America.

[161]  E. Keeffe,et al.  Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy , 2001, American Journal of Gastroenterology.

[162]  M. Losowsky,et al.  PERCUTANEOUS LIVER BIOPSY WITH PLUGGING OF NEEDLE TRACK: A SAFE METHOD FOR USE IN PATIENTS WITH IMPAIRED COAGULATION , 1984, The Lancet.

[163]  F. Reinholt,et al.  Liver biopsy interpretation for causes of late liver allograft dysfunction , 2006, Hepatology.

[164]  P. Bejarano,et al.  Second opinion pathology in liver biopsy interpretation , 2001, American Journal of Gastroenterology.

[165]  F. Leebeek,et al.  A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis. , 1991, Gastroenterology.

[166]  M. Khuroo,et al.  Percutaneous drainage compared with surgery for hepatic hydatid cysts. , 1997, The New England journal of medicine.

[167]  K. Reddy,et al.  Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management , 2006, Hepatology.

[168]  F. Degos,et al.  Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey , 2000, Hepatology.

[169]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[170]  J. Goedert,et al.  Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[171]  B J Ott,et al.  A 21-year experience with major hemorrhage after percutaneous liver biopsy. , 1990, Gastroenterology.

[172]  D. Samuel,et al.  Could post‐liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? , 2005, Clinical transplantation.

[173]  A. Andriulli,et al.  To biopsy or not to biopsy. , 2001, Hepatology.

[174]  P. Mannucci,et al.  The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions. , 2008, Journal of thrombosis and haemostasis : JTH.

[175]  B. Bacon,et al.  Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications. , 1994, Gastroenterology.

[176]  T. Riley,et al.  The Effect of Processing on Liver Biopsy Core Size , 2008, Digestive Diseases and Sciences.

[177]  B. Healy,et al.  Effect of fresh‐frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities , 2006, Transfusion.

[178]  T. Therneau,et al.  Cost‐effectiveness of ultrasound‐guided liver biopsy , 1998, Hepatology.

[179]  N. Talley,et al.  Diagnostic value of liver biopsy in alcoholic liver disease. , 1988, Journal of clinical gastroenterology.

[180]  M. Gambardella,et al.  Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity , 2001, Hepatology.

[181]  J. Epstein,et al.  Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When. , 2000, American journal of clinical pathology.

[182]  K. Ewe Bleeding after liver biopsy does not correlate with indices of peripheral coagulation , 1981, Digestive Diseases and Sciences.

[183]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[184]  P. Galle,et al.  Prospective Randomized Comparison of Minilaparoscopy and Percutaneous Liver Biopsy: Diagnosis of Cirrhosis and Complications , 2007, Journal of clinical gastroenterology.

[185]  Barbara J. Smith,et al.  Midazolam sedation for percutaneous liver biopsy , 1993, Digestive Diseases and Sciences.

[186]  A. Clouston,et al.  Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis , 1999, Hepatology.

[187]  K. Batts,et al.  Chronic hepatitis. An update on terminology and reporting. , 1995, The American journal of surgical pathology.

[188]  J. Trotter,et al.  Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease , 2007, Alimentary pharmacology & therapeutics.

[189]  P. Mannucci,et al.  Thrombin generation in patients with cirrhosis: The role of platelets , 2006, Hepatology.

[190]  Don C Rockey,et al.  Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. , 2008, Gastroenterology.

[191]  D. Theriaque,et al.  One‐year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[192]  M. Swain,et al.  A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful? , 2005, American journal of hematology.

[193]  D. Nelson,et al.  Short recovery time after percutaneous liver biopsy: should we change our current practices? , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[194]  A. Clouston,et al.  Steatosis: Co‐factor in other liver diseases , 2005, Hepatology.

[195]  J. Trotter,et al.  A Survey of Current Liver Biopsy Practice Patterns , 2000, Journal of clinical gastroenterology.

[196]  G Goldfarb,et al.  Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. , 1982, Gastroenterology.

[197]  C. Brown,et al.  BLEEDING IN RENAL FAILURE , 1988, The Lancet.

[198]  P. Simmonds,et al.  Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non‐invasive methods , 1996, British journal of haematology.

[199]  A. Reuben The legend of the lardaceous liver , 2004, Hepatology.

[200]  Y. Batur,et al.  Liver Biopsy: Is the Pain for Real or is it Only the Fear of it? , 2007, Digestive Diseases and Sciences.

[201]  J. Madura,et al.  The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures. , 1994, The American surgeon.

[202]  E. Cholongitas,et al.  Transjugular liver biopsy in patients with diffuse liver disease: comparison of three cores with one or two cores for accurate histological interpretation , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[203]  A. Gaspari,et al.  Percutaneous Liver Biopsy Using an Ultrasound-Guided Subcostal Route , 2004, Digestive Diseases and Sciences.

[204]  Chia-Yen Dai,et al.  The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies , 2007, Gut.